4th Quarter - Amendment

LINCOLN POLICY GROUP for FRESENIUS MEDICAL CARE NORTH AMERICA

Firm
Client
Income
$50,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report Jan 21, 2020 $50,000 Replaced
4th Quarter - Amendment (this page) Apr 24, 2020 $50,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities.

Foreign entity interest: Fresenius Medical Care AG, identified on form LD-1, has an interest in the activities of its U.S. subsidiary Fresenius Medical Care North America on all issues.

LobbyistCovered position, as disclosed
DAN ELLING —
RUDY MISSMAR —
COLIN ROSKEY New Health Policy Advisor and Counsel, Senate Finance Committee
THOMAS A SCULLY —
REGINA MARIA SHERICK —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: S. 2065 (116th), H.R. 4143 (116th)

Medicare/Medicaid MMM

S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities.

Foreign entity interest: Fresenius Medical Care AG, identified on form LD-1, has an interest in the activities of its U.S. subsidiary Fresenius Medical Care North America on all issues.

LobbyistCovered position, as disclosed
DAN ELLING —
RUDY MISSMAR —
COLIN ROSKEY New Health Policy Advisor and Counsel, Senate Finance Committee
THOMAS A SCULLY —
REGINA MARIA SHERICK —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 2065 (116th), H.R. 4143 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.